The Future of Market Access in the U.S.

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2gTK2a7 on October 20, 2017 at 03:42PM When it comes to the affordability challenge, have payers and drugmakers reached a stalemate in the U.S.? Pricing wars continue to rage, pharma initiatives are having lackluster impact, and payers are still not happy. At the same time, U.S. President Donald […]

The AEA and the job market

from Market Design at http://bit.ly/2xbjrLM on October 20, 2017 at 03:13PM Should the American Economic Association make further interventions to facilitate the job market for new economists?  Should it issue a code of conduct to guide behavior in various realms in which economists interact?  Both of those are under consideration, as announced today on the […]

Robinson: ‘New York is Big Pharma Battleground’

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2yxLkBo on October 20, 2017 at 03:12PM David Robinson with lohud calls New York a “big pharma battleground,” citing a problematic relationship between pharma’s “boom-or-bust” history and patient needs. “In many ways, the high-stakes bets and pharma speculation threatening New York drug companies is endangering the future of […]

Kristensen, Reed and Watkins Discuss HTA

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2yDajBc on October 20, 2017 at 02:41PM Science and Policy Managing Director Finn Kirstensen, Duke Clinical Research Institute Professor Shelby Reed and Premera Blue Cross Pharmacy Manager John Watkins discussed health technology assessments (HTA) during the Academy of Managed Care Pharmacy’s Nexus 2017. Click here to read more […]